Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 2003 Sep 27;327(7417):708-13.
doi: 10.1136/bmj.327.7417.708.

Rapid tranquillisation for agitated patients in emergency psychiatric rooms: a randomised trial of midazolam versus haloperidol plus promethazine

TREC Collaborative Group
Clinical Trial

Rapid tranquillisation for agitated patients in emergency psychiatric rooms: a randomised trial of midazolam versus haloperidol plus promethazine

TREC Collaborative Group. BMJ. .

Abstract

Objective: To compare two widely used drug treatments for people with aggression or agitation due to mental illness.

Design: Pragmatic, randomised clinical trial.

Setting: Three psychiatric emergency rooms in Rio de Janeiro, Brazil.

Subjects: 301 aggressive or agitated people.

Interventions: Open treatment with intramuscular midazolam or intramuscular haloperidol plus promethazine.

Main outcome measures: Patients tranquil or sedated at 20 minutes.

Secondary outcomes: patients tranquil or asleep by 40, 60, and 120 minutes; restrained or given extra drugs within 2 hours; severe adverse events; another episode of agitation or aggression; needing extra visits from doctor during first 24 hours; overall antipsychotic load in first 24 hours; and not discharged by two weeks.

Results: 151 patients were randomised to midazolam, and 150 to haloperidol-promethazine mix. Follow up for the primary outcome was available for 298 (99%): 134/151 (89%) of patients given midazolam were tranquil or asleep after 20 minutes compared with 101/150 (67%) of those given haloperidol plus promethazine (relative risk 1.32 (95% confidence interval 1.16 to 1.49)). By 40 minutes, midazolam still had a statistically and clinically significant 13% relative advantage (1.13 (1.01 to 1.26)). After 1 hour, about 90% of both groups were tranquil or asleep. One important adverse event occurred in each group: a patient given midazolam had transient respiratory depression, and one given haloperidol-promethazine had a grande mal seizure.

Conclusions: Both treatments were effective. Midazolam was more rapidly sedating than haloperidol-promethazine, reducing the time people are exposed to aggression. Adverse effects and resources to deal with them should be considered in the choice of the treatment.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Flow of patients through various stages of TREC study
See this image and copyright information in PMC

Comment in

References

    1. McAllister-Williams RH, Ferrier IN. Rapid tranquillisation: time for a reappraisal of options for parenteral therapy. Br J Psychiatry 2002;180: 485-9. - PubMed
    1. Kaplan HI, Sadock BJ, Grebb JA. Kaplan and Sadock's synopsis of psychiatry. 7th ed. Baltimore: Williams and Wilkins, 1994.
    1. Expert Consensus Guideline Group. Treatment of schizophrenia 1999. The expert consensus guideline series. J Clin Psychiatry 1999;60(suppl 11): 3-80. - PubMed
    1. Wing JK, Marriott S, Palmer C, Thomas V. The management of imminent violence: clinical practice guidelines to support mental health services. London: Royal College of Psychiatrists, 1998. (Occasional paper OP41.)
    1. Cunnane JG. Drug management of disturbed behaviour by psychiatrists. Psychiatr Bull 1994;18: 138-9.

MeSH terms